5th Floor, Brigade Towers,
Financial District, Gachibowli,
Hyderabad - 500032,
The Contraceptive Pills Market is segmented by Hormone Type (Progestin Pills and Combination Pills), Category, and Geography.
Fastest Growing Market:
The market is expected to register a CAGR of nearly 9%, during the forecast period, 2019 - 2024. It is segmented by hormone type, category, and geography.
As per the scope of the report, contraceptive pill is a kind of medicine with hormones, which generally comes in a pack. Contraceptive pills are affordable and effective, and offer other health benefits. The contraceptive pill works by stopping the sperm from joining with an egg during fertilization. The hormones in the pill stop ovulation. Furthermore, these hormones thicken the mucus on the cervix, thus, blocking the sperm.
|By Hormone Type|
Report scope can be customized per your requirements. Click here.
The generic segment has the largest share in the market, due to the widespread adoption of generic contraceptives, owing to their low prices and ease of use. Furthermore, the increasing need for population control and rising incidence of abortion have driven the growth of generic contraceptive pills in the market. There has been a dramatic increase in the availability of various birth control pills in the United States, as a result of implementation of the Drug Price Competition and Patent Term Restoration Act of 1984 (Hatch-Waxman Act), which set up the modern system of generic drug approval and regulation. Physicians, pharmacists, and women can choose pills based on price, as the action of these contraceptives, or their therapeutic equivalence, was essentially the same. Major manufacturers in the market are finding ways to make their products stand out from the crowd. Thus, all these initiatives are expected to propel the growth of the market during the forecast period.
To understand key trends, Download Sample Report
North America dominates the contraceptive pills market, owing to rapid developments in the healthcare infrastructure and high awareness about contraceptive pills in the region. In 2017, there were approximately 60 million women in the United States in their child-bearing age (age: 15 - 44). Around 70% of these women were at the risk of unintended pregnancy. More than 99% of women aged between 15 - 44 years have used at least one contraceptive method. This indicates the high awareness about and demand for contraceptives, for avoiding unintended pregnancies, in the United States. Additionally, contraceptive pills account for the largest share of expenditure on contraceptive methods in the United States.
To understand geography trends, Download Sample Report.
The competition in the market is set to intensify, as several key players in are focusing on the expansion of their product portfolios, through acquisitions and collaborations. The contraceptive pills market is expected to open up several opportunities for the new players, as well as the currently established market leaders. The key players in the market include Bayer Healthcare, Amgen Inc., Baxter, Gilead Sciences Inc., and GlaxoSmithKline PLC, among others.
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Awareness about Contraceptive Pills
4.2.2 Need to Prevent Unwanted Abortions
4.2.3 Ease of Use and Low Cost
4.3 Market Restraints
4.3.1 Side Effects Associated with the Use of Contraceptive Drugs
4.3.2 Increased Usage of Alternative Birth Control Methods
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Hormone Type
5.1.1 Progestin Pills
5.1.2 Combination Pills
184.108.40.206 Other Combination Pills
5.2 By Category
5.3.1 North America
220.127.116.11 Rest of Europe
18.104.22.168 South Korea
22.214.171.124 Rest of Asia-Pacific
5.3.4 Middle East & Africa
126.96.36.199 South Africa
188.8.131.52 Rest of Middle East & Africa
5.3.5 South America
184.108.40.206 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Bayer Healthcare
6.1.2 Amgen Inc.
6.1.4 Gilead Sciences Inc.
6.1.5 GlaxoSmithKline PLC
6.1.6 Johnson & Johnson
6.1.7 Merck & Co. Inc.
6.1.8 Novartis AG
6.1.9 Pfizer Inc.
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject to Availability
**Competitive Landscape Covers - Business Overview, Financials, Products, Strategies, and Recent Developments